Fully Integrated Pharma and Biopharma R&D, Development & Manufacturing – CDMO
Chinese pharma conglomerate WuXi AppTec, already a staple of the Asian life science markets, sought to penetrate the Western market with its vast integrated CDMO offering. North American and European trade shows presented a unique opportunity for WuXi’s sales teams to put the company’s name and offering in front of Western buyers.